Dokter Ledegen Lars SRL

Dokter Ledegen Lars reported total assets of 179,053 € at the end of the 2025 financial year (annual accounts filed with the NBB on 07 May 2026).

Company number (CBE) 0730.930.929 · VAT BE0730930929
2020 Antwerp
active in General medical practice activities (NACE 86210)
operating since 22 Jul 2019 (≈ 7 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Dokter Ledegen Lars shows with a free account.

See the score
Profile
SRL since 2019
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result190,823 €
Equity500 €
Cash120,547 €
EBITDA249,458 €
Total assets179,053 €
The line marks its sector median: 72.4% (5478 companies).

Change 2022 → 2025: Equity -95 % Total assets -10 %

Accounts of the company itself (not consolidated).

The full file covers 7 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Dokter Ledegen Lars's annual accounts

20252024202320222021
Net result190,823 €
Equity500 €
Cash120,547 €
EBITDA249,458 €
Total assets179,053 €

Filed annual accounts

  • Year ended 31 Dec 2025filed on 07 May 2026
  • Year ended 31 Dec 2024filed on 12 Jun 2025
  • Year ended 31 Dec 2023filed on 27 May 2024
  • Year ended 31 Dec 2022filed on 11 Jul 2023
  • Year ended 31 Dec 2021filed on 28 Jun 2022

Dokter Ledegen Lars's financial analysis

Management and control of Dokter Ledegen Lars

1 active director(s) in the register.

Dokter Ledegen Lars's shareholders and holdings →

Dokter Ledegen Lars's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0730.930.929
VAT number
BE0730930929
Peppol
Registered · 0208:0730930929 · as of 10 Nov 2026
Legal form
SRL
Incorporated
22 Jul 2019
Registered office
2020 Antwerp
Latest accounts
2025 · filed on 07 May 2026
Activity
General medical practice activities (NACE 86210)

Dokter Ledegen Lars (SRL) has been based in Antwerp since 2019, active in: general medical practice activities. For 2025, it reports a net profit of 190,823 € and equity of 500 €; its revenue is not published.

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Dokter Ledegen Lars

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Dokter Ledegen Lars

What is the revenue of Dokter Ledegen Lars?

Dokter Ledegen Lars files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of Dokter Ledegen Lars?

In Belgium, the VAT number is the company number prefixed with BE: BE0730930929 for Dokter Ledegen Lars, if the company is VAT-registered. Its company number (CBE) is 0730.930.929.

Where is the registered office of Dokter Ledegen Lars?

According to the CBE register, the registered office of Dokter Ledegen Lars is in 2020 Antwerp.

What is the equity of Dokter Ledegen Lars?

At the close of the 2025 financial year, the equity of Dokter Ledegen Lars amounts to 500 €, a solvency of 0.3% of total assets.

Who manages Dokter Ledegen Lars?

The register lists 1 active mandates at Dokter Ledegen Lars. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of Dokter Ledegen Lars

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 19 Sep 2026

No credit card, no commitment.

What each plan unlocks →